Literature DB >> 22237820

The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation.

S Jarius1, B Wildemann.   

Abstract

The recent discovery of disease specific and pathogenic autoantibodies in neuromyelitis optica (NMO, Devic's disease) has revived the interest in this intriguing yet often devastating condition. While the history of classic multiple sclerosis has been studied extensively, only very little is known so far about the early history of NMO. Here we discuss a now forgotten report by the famous French anatomist and pathologist Antoine Portal (1742-1832), first physician to Louis XVIII and founding and lifelong president of the Académie Nationale de Médecine. Portal's report, which fascinated some of the most renowned 19th century pioneers in the field of neurology but fell into oblivion later, represents the first account of visual loss in a patient with spinal cord inflammation but no brain pathology in the Western literature known so far--published more than 60 years prior to Thomas Clifford Allbutt's much cited note on a patient with myelitis and a "sympathetic eye disorder".

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237820     DOI: 10.1007/s00415-011-6355-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  Intractable vomiting as the initial presentation of neuromyelitis optica.

Authors:  Metha Apiwattanakul; Bogdan F Popescu; Marcelo Matiello; Brian G Weinshenker; Claudia F Lucchinetti; Vanda A Lennon; Andrew McKeon; Adam F Carpenter; Gary M Miller; Sean J Pittock
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

2.  NMO-IgG in the diagnosis of neuromyelitis optica.

Authors:  S Jarius; D Franciotta; R Bergamaschi; H Wright; E Littleton; J Palace; R Hohlfeld; A Vincent
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

3.  Hiccups, nausea, and vomiting: water channels under attack!

Authors:  Joanne Riphagen; Piet Modderman; Aad Verrips
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

4.  Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Jakub Závada; P Nytrová; K P Wandinger; S Jarius; R Svobodová; C Probst; V Peterová; D Tegzová; K Pavelka; J Vencovský
Journal:  Rheumatol Int       Date:  2011-10-29       Impact factor: 2.631

5.  An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS.

Authors:  S Jarius; B Wildemann
Journal:  Mult Scler       Date:  2011-06-20       Impact factor: 6.312

6.  'Noteomielite' accompanied by acute amaurosis (1844). An early case of neuromyelitis optica.

Authors:  S Jarius; B Wildemann
Journal:  J Neurol Sci       Date:  2011-10-10       Impact factor: 3.181

Review 7.  Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Authors:  Sven Jarius; Friedemann Paul; Diego Franciotta; Patrick Waters; Frauke Zipp; Reinhard Hohlfeld; Angela Vincent; Brigitte Wildemann
Journal:  Nat Clin Pract Neurol       Date:  2008-03-11

8.  Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.

Authors:  Makoto Kinoshita; Yuji Nakatsuji; Takashi Kimura; Masayuki Moriya; Kazushiro Takata; Tatsusada Okuno; Atsushi Kumanogoh; Koji Kajiyama; Hiroo Yoshikawa; Saburo Sakoda
Journal:  Biochem Biophys Res Commun       Date:  2009-06-21       Impact factor: 3.575

9.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

10.  Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis.

Authors:  Dragan Lepur; Vjerislav Peterković; Nevija Kalabrić-Lepur
Journal:  Neurol Sci       Date:  2009-01-15       Impact factor: 3.830

View more
  16 in total

Review 1.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 2.  Neuro-ophthalmology update.

Authors:  Konrad P Weber; Dominik Straumann
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

3.  Evaluation of aquaporin-4 antibody assays.

Authors:  Patrick J Waters; Sean J Pittock; Jeffrey L Bennett; Sven Jarius; Brian G Weinshenker; Dean M Wingerchuk
Journal:  Clin Exp Neuroimmunol       Date:  2014-04-22

Review 4.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

5.  On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.

Authors:  S Jarius; B Wildemann
Journal:  J Neurol       Date:  2012-07-11       Impact factor: 4.849

6.  The history of neuromyelitis optica.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

Review 7.  Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.

Authors:  Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

8.  'Spinal amaurosis' (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica.

Authors:  S Jarius; B Wildemann
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

Review 9.  [Neuromyelitis optica].

Authors:  B Wildemann; S Jarius; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 10.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.